Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8444187 | 0.98 | APEX1 (0.31) | APEX1 | |
| SCHEMBL8441447 | 0.74 | — | — | |
| SCHEMBL13685332 | 0.74 | APEX1 (0.35) | APEX1 | |
| SCHEMBL536916 | 0.74 | APEX1 (0.35) | APEX1 | |
| SCHEMBL3311523 | 0.72 | APEX1 (0.31) | APEX1 | |
| SCHEMBL8150337 | 0.72 | TSHR (0.44) | APEX1 | |
| SCHEMBL13685385 | 0.72 | TSHR (0.33) | APEX1 | |
| SCHEMBL151234 | 0.72 | APEX1 (0.36) | APEX1 | |
| SCHEMBL642406 | 0.72 | TSHR (0.33) | APEX1 | |
| SCHEMBL7639061 | 0.72 | APEX1 (0.36) | APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2544812-B1 | IMPROVED MICROCAPSULES AND PRODUCTION THEREOF | FOLLMANN GMBH & CO KG (DE) | 2018-10-24 | — | — | EP | claimed |
| EP-0831932-A4 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP (US) | 2000-01-12 | — | — | EP | claimed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| US-8591949-B2 | Aqueous compositions comprising a chemical microgel associated with an aqueous polymer | RHODIA CHIMIE (FR) | 2013-11-26 | — | — | US | disclosed |
| US-8497062-B2 | Resin for formation of upper antireflective film, composition for formation of upper antireflective film, and resist pattern formation method | JSR CORPORATION (JP) | 2013-07-30 | — | — | US | disclosed |
| US-7820752-B2 | Use of charged amphiphilic statistic polymers for thickening phase comprising giant micelles of surfactants and aqueous composition comprising same | RHODIA CHIMIE (FR) | 2010-10-26 | — | — | US | disclosed |
| US-20100112475-A1 | RESIN FOR FORMATION OF UPPER ANTIREFLECTIVE FILM, COMPOSITION FOR FORMATION OF UPPER ANTIREFLECTIVE FILM, AND RESIST PATTERN FORMATION METHOD | JSR CORPORATION (JP) | 2010-05-06 | — | — | US | disclosed |
| US-7589144-B2 | The inverse emulsion comprising an internal aqueous phase that has hydrophilic active substance dispersed in an organic phase and an external aqueous phase comprising polyalkoxylated amphiphilic nonionic polymer (or surfactant), and a water-soluble or water-dispersible polymer; easy storage, transporting | RHODIA CHIMIE (FR) | 2009-09-15 | — | — | US | disclosed |
| US-7579400-B2 | Particles having an organized internal structure which are dispersed in an aqueous phase, the preparation thereof and use of same | RHODIA CHIMIE (FR) | 2009-08-25 | — | — | US | disclosed |
| US-20090131578-A1 | Aqueous Compositions Comprising A Chemical Microgel Associated With An Aqueous Polymer | RHODIA CHIMIE (FR) | 2009-05-21 | — | — | US | disclosed |
| US-7319117-B2 | Method for preparing a water/oil/water multiple emulsion | RHODIA CHIMIE (FR) | 2008-01-15 | — | — | US | disclosed |
| US-20050169946-A1 | Cosmetic formulation comprising at least two active substances in a multiple emulsion optionally mixed with a single emulsion | CHIMIE, RHODIA (FR) | 2005-08-04 | — | — | US | disclosed |
| US-20050119401-A1 | Use of charged amphiphilic statistic polymers for thickening phase comprising giant micelles of surfactants and aqueous composition comprising same | RHODIA CHIMIE (FR) | 2005-06-02 | — | — | US | disclosed |
| US-20050053569-A1 | Use of cationic block copolymers to assist the deposition of simple or multiple emulsions | RHODIA CHIMIE (FR) | 2005-03-10 | — | — | US | disclosed |
| US-20050019352-A1 | Method for preparing a water/oil/water multiple emulsion | RHODIA CHIMIE (FR) | 2005-01-27 | — | — | US | disclosed |
| US-20040219215-A1 | Aqueous compositions comprising a chemical microgel associated with an aqueous polymer | RHODIA CHIMIE (FR) | 2004-11-04 | — | — | US | disclosed |
| US-20040213854-A1 | can make available high concentrations of active material(s) in solid formulations, and also make possible a release that is spread over time and/or triggered from said active ingredient, once the formulation has been applied | CHIMIE, RHODIA (FR) | 2004-10-28 | — | — | US | disclosed |
| US-20040170657-A1 | Dispersion comprising an emulsion having an aqueous phase with high ionic strength | RHODIA CHIMIE (FR) | 2004-09-02 | — | — | US | disclosed |
| US-20040054076-A1 | Method for preparing an emulsion with high-viscosity organic phase | RHODIA CHIMIE (FR) | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050053569-A1 | Use of cationic block copolymers to assist the deposition of simple or multiple emulsions | ABCB4, APOB, CHMP4B | APEX1 1595/4885 |
| US-20040170657-A1 | Dispersion comprising an emulsion having an aqueous phase with high ionic strength | SAMM50, IPO5, IPO7 | APEX1 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.